I agree I am not sure if everybody fully understands how big this can be. I am disappointed that the news Didn't hit all outlets but long term guess it really Doesn't matter.
Alyssa - if you look at the big picture here, I believe that buying at these prices is a no brainer... just on the last 2 news releases. That doesn't even take into account all the other drugs that they have in the pipeline.
I didn't even think about an acquisition. I was purely thinking of the run that it will take on its own merit based on sales and product advancements/distribution. An acquisition is a very interesting and valid point.